Fontana V - Search Results

1

Decoding resistant hypertension signalling pathways.

Parreira RC, Lacerda LHG, Vasconcellos R, Lima SS, Santos AK, Fontana V, Sandrim VC, Resende RR. Parreira RC, et al. Among authors: fontana v. Clin Sci (Lond). 2017 Nov 28;131(23):2813-2834. doi: 10.1042/CS20171398. Print 2017 Dec 1. Clin Sci (Lond). 2017. PMID: 29184046 Review.

2

Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension.

Lacerda L, Faria AP, Fontana V, Moreno H, Sandrim V. Lacerda L, et al. Among authors: fontana v. Arq Bras Cardiol. 2015 Aug;105(2):168-75. doi: 10.5935/abc.20150060. Epub 2015 Jun 2. Arq Bras Cardiol. 2015. PMID: 26039662 Free PMC article.

3

An update on the pharmacogenetics of treating hypertension.

Fontana V, Luizon MR, Sandrim VC. Fontana V, et al. J Hum Hypertens. 2015 May;29(5):283-91. doi: 10.1038/jhh.2014.76. Epub 2014 Aug 28. J Hum Hypertens. 2015. PMID: 25355012 Review.

4

Adipokines: novel players in resistant hypertension.

de Faria AP, Modolo R, Fontana V, Moreno H. de Faria AP, et al. Among authors: fontana v. J Clin Hypertens (Greenwich). 2014 Oct;16(10):754-9. doi: 10.1111/jch.12399. Epub 2014 Sep 4. J Clin Hypertens (Greenwich). 2014. PMID: 25186286 Free PMC article. Review.

5

Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension.

de Faria AP, Fontana V, Modolo R, Barbaro NR, Sabbatini AR, Pansani IF, Ferreira-Melo SE, Moreno H. de Faria AP, et al. Among authors: fontana v. Clin Chim Acta. 2014 Jun 10;433:179-83. doi: 10.1016/j.cca.2014.03.009. Epub 2014 Mar 19. Clin Chim Acta. 2014. PMID: 24657423

6

Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers.

Barbaro NR, Fontana V, Modolo R, De Faria AP, Sabbatini AR, Fonseca FH, Anhê GF, Moreno H. Barbaro NR, et al. Among authors: fontana v. Blood Press. 2015 Feb;24(1):7-13. doi: 10.3109/08037051.2014.940710. Epub 2014 Jul 25. Blood Press. 2015. PMID: 25061978 Clinical Trial.

7

Increased Circulating Tissue Inhibitor of Metalloproteinase-2 Is Associated With Resistant Hypertension.

Sabbatini AR, Barbaro NR, de Faria AP, Modolo R, Ritter AM, Pinho C, Amorim RF, Fontana V, Moreno H. Sabbatini AR, et al. Among authors: fontana v. J Clin Hypertens (Greenwich). 2016 Oct;18(10):969-975. doi: 10.1111/jch.12865. Epub 2016 Jul 14. J Clin Hypertens (Greenwich). 2016. PMID: 27412873 Free PMC article.

8

Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension.

de Faria AP, Demacq C, Figueiredo VN, Moraes CH, Santos RC, Sabbatini AR, Barbaro NR, Boer-Martins L, Fontana V, Moreno H Jr. de Faria AP, et al. Among authors: fontana v. Hypertens Res. 2013 Dec;36(12):1067-72. doi: 10.1038/hr.2013.92. Epub 2013 Aug 22. Hypertens Res. 2013. PMID: 23966059

9

Deregulation of adipokines related to target organ damage on resistant hypertension.

Sabbatini AR, Faria AP, Barbaro NR, Gordo WM, Modolo RG, Pinho C, Fontana V, Moreno H. Sabbatini AR, et al. Among authors: fontana v. J Hum Hypertens. 2014 Jun;28(6):388-92. doi: 10.1038/jhh.2013.118. Epub 2013 Nov 28. J Hum Hypertens. 2014. PMID: 24284384

10

Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension.

Santos RC, de Faria AP, Barbaro NR, Modolo R, Ferreira-Melo SE, Matos-Souza JR, Coelho OR, Yugar-Toledo JC, Fontana V, Calhoun D, Moreno H. Santos RC, et al. Among authors: fontana v. Eur J Clin Pharmacol. 2014 Feb;70(2):147-54. doi: 10.1007/s00228-013-1611-8. Epub 2013 Nov 24. Eur J Clin Pharmacol. 2014. PMID: 24271647 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page